NCT00805129
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Clinical trial condition
Carcinoma, Transitional Cell
Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.
430 public trials
126 recruiting studies
Carcinoma, Transitional Cell trial results
Completed
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
NCT00623831
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +50 more
- Locations
-
- Krankenhaus Nordwest Frankfurt, Germany
NCT03584659
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
- Locations
-
- Aalborg University Hospital Aalborg, Denmark
- Department of Oncology, Rigshospitalet Copenhagen, Denmark
- Department of Oncology Herlev, Denmark
- Odense University Hospital Odense, Denmark
NCT01688999
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +17 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT00070070
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT02500121
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
- Locations
-
- University of Arizona at Dignity Health St. Joseph's Phoenix, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- Georgetown University Washington D.C., District of Columbia, United States
NCT03410693
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +2 more
- Locations
-
- Alaska Clinical Research Center, LLC Anchorage, Alaska, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
- University of Southern California Los Angeles, California, United States
- UC Davis Comprehensive Cancer Center Sacramento, California, United States
NCT03241173
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +74 more
- Locations
-
- The University of Alabama Birmingham (UAB) Birmingham, Alabama, United States
- Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States
- The Angeles Clinic and Research Institute Los Angeles, California, United States
- Mount Sinai Medical Center of Florida, Inc. Miami, Florida, United States
Completed
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
NCT03558503
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
- Locations
-
- Mayo Clinic Cancer Center Phoenix, Arizona, United States
- Arkansas Urology Little Rock, Arkansas, United States
- Loma Linda University Loma Linda, California, United States
- Providence Medical Institute Santa Monica, California, United States
NCT04077359
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
- Locations
-
- Oslo University Hospital Oslo, Norway